Abstract
TNF is a major proinflammatory cytokine, which exerts its effects through two different receptors known as TNF-R1 and TNF-R2. Whereas TNF-R1 induced signaling pathways have been very well characterized during the past years, TNF-R2 has been much less well studied. Nevertheless, the function of TNF-R2 should not be underestimated, the more because this receptor shows a much more restricted but inducible expression. Several inflammatory diseases and cancers show upregulated levels of soluble TNF-R2 or are associated with TNF-R2 polymorphisms, implicating an important role for TNF-R2 as a therapeutic target. Here we will review the mechanisms that regulate TNF-R2 expression, as well as discuss TNF-R2 induced signal transduction and cross-talk with TNF-R1.
Keywords: tumor necrosis factor receptor (tnf-r), signal transduction, apoptosis, inflammation, cd120b, disease, polymorphisms
Current Medicinal Chemistry
Title: Function and Regulation of Tumor Necrosis Factor Receptor Type 2
Volume: 11 Issue: 16
Author(s): I. Carpentier, B. Coornaert and R. Beyaert
Affiliation:
Keywords: tumor necrosis factor receptor (tnf-r), signal transduction, apoptosis, inflammation, cd120b, disease, polymorphisms
Abstract: TNF is a major proinflammatory cytokine, which exerts its effects through two different receptors known as TNF-R1 and TNF-R2. Whereas TNF-R1 induced signaling pathways have been very well characterized during the past years, TNF-R2 has been much less well studied. Nevertheless, the function of TNF-R2 should not be underestimated, the more because this receptor shows a much more restricted but inducible expression. Several inflammatory diseases and cancers show upregulated levels of soluble TNF-R2 or are associated with TNF-R2 polymorphisms, implicating an important role for TNF-R2 as a therapeutic target. Here we will review the mechanisms that regulate TNF-R2 expression, as well as discuss TNF-R2 induced signal transduction and cross-talk with TNF-R1.
Export Options
About this article
Cite this article as:
Carpentier I., Coornaert B. and Beyaert R., Function and Regulation of Tumor Necrosis Factor Receptor Type 2, Current Medicinal Chemistry 2004; 11(16) . https://dx.doi.org/10.2174/0929867043364694
DOI https://dx.doi.org/10.2174/0929867043364694 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Headache in Multiple Sclerosis - Pharmacological Aspects
Current Pharmaceutical Design Methylation Profile of miR-9-1 and miR-9-1/-9-3 as Potential Biomarkers of Diabetic Retinopathy
Current Diabetes Reviews Effects of Propolis and Caffeic Acid Phenethyl Ester (CAPE) on Breast Cancer Cells
Current Pharmacogenomics and Personalized Medicine Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine Carbohydrate-Based Recognition Systems in Primary Open Angle Glaucoma
Current Organic Chemistry Distinct Functions of Retinoic Acid Receptor Beta Isoforms: Implications for Targeted Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Electroporation: An Effective Method For <i>In Vivo</i> Gene Delivery
Drug Delivery Letters Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry The Eker Rat: Establishing a Genetic Paradigm Linking Renal Cell Carcinoma and Uterine Leiomyoma
Current Molecular Medicine Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Antiplatelet Effects of Bioactive Compounds Present in Tomato Pomace
Current Drug Targets ABCC6 as a Target in Pseudoxanthoma Elasticum
Current Drug Targets Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin
Current Pharmaceutical Design Randomised Trials of Graft Versus Host Disease Prophylaxis in Haemopoietic Stem Cell Transplantation
Reviews on Recent Clinical Trials Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Nanocrystal Based Drug Delivery System: Conventional and Current Scenario
Recent Patents on Nanotechnology Scaffold Vascularization: A Challenge for Three-Dimensional Tissue Engineering
Current Medicinal Chemistry Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation
Current Stem Cell Research & Therapy Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and Neoangiogenesis
Current Medicinal Chemistry Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases
Current Pharmaceutical Design